Secteur Taysha Gene Therapies, Inc.

Actions

TSHA

US8776191061

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 24/07/2026 Varia. 5j. Varia. 1 janv.
5,520 USD -5,32% Graphique intraday de Taysha Gene Therapies, Inc. -7,38% +0,36%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-5,32%-7,38%-12,93%-13,75%+0,36%+108,30%+752,51%-69,25% - 1,77 Md
-0,30%+6,42%+2,11%+18,43%+11,89%+56,70%+70,97%+219,39%+6 117,05% 57,28 Md
-1,92%+6,03%+5,77%+24,90%+37,91%+40,64%+80,66%-15,96% - 54,99 Md
-0,46%-1,29%+3,42%-20,90%-38,57%+2,86%+425,15%+347,36%+878,23% 23,18 Md
-2,97%-2,35%-2,07%-15,29%-6,17%-22,53%-15,34%-68,79% - 22,59 Md
-1,13%+1,05%+9,58%+16,17%+22,96%+20,81%-7,73%-64,17% - 20,46 Md
+0,29%+1,87%+9,49%+10,22%-7,18%+25,64%-30,06%-31,71%+57,71% 17,56 Md
-0,10%+1,88%+17,88%+10,05%+30,93%+34,42%+545,91% - - 15,67 Md
-1,30%-5,02%+9,01%+103,07%+167,88%+170,77%+310,94%+1 485,91%+635,36% 14,46 Md
-0,50%-0,98%+1,10%+23,21%+26,33%+21,43%+179,36%+235,37%+540,86% 13,92 Md
+0,21%-1,62%+6,21%+6,27%-6,50%+82,48%+170,44%+537,45%+6 045,71% 12,55 Md
-1,36%+15,21%+8,51%+15,82%+28,94%+443,84%+143,87%+28,28%+1 388,70% 12,06 Md
-0,90%+5,62%+7,58%-28,19%-12,74%-34,53%+141,08%+116,70% - 11,69 Md
-1,44%+0,70%-1,76%+23,61%+27,07%+117,16%+149,20%+186,31%+716,38% 10,96 Md
-8,81%-1,09%-2,50%-38,13%-21,90%-52,35%+596,94%+79,03%+91,05% 10,9 Md
+2,14%+1,90%+16,20%+46,59%+211,75%+474,09%+615,45%-37,05%-13,08% 8,98 Md
+0,10%-0,16%+128,15%+118,45%+79,87%+170,18%+343,96%+355,30% - 8,83 Md
-4,27%+3,96%+27,57%+25,09%+14,49%+24,00%+316,05%+317,80% - 7,92 Md
-1,76%-2,74%-3,29%-8,12%+18,47%+49,22%+16,10%+141,64% - 7,89 Md
-4,05%-7,55%-18,48%-4,57%+258,59%+148,25%+190,98%-34,56% - 7,44 Md
Moyenne -1,69%+0,75%+10,58%+15,65%+42,22%+94,07%+249,82%+196,27%+1 645,80% 17,05 Md
Moyenne pondérée par Capi. -1,32%+2,00%+8,18%+15,83%+30,26%+69,05%+177,30%+179,76%+2 693,55%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action TSHA
  4. Secteur Taysha Gene Therapies, Inc.